Assessment of baseline pretreatment factors and on-treatment virological response to predict sustained virological response in patients with chronic hepatitis C treated with pegylated interferon and ribavirin-Reference-Cited by-同舟云学术

Assessment of baseline pretreatment factors and on-treatment virological response to predict sustained virological response in patients with chronic hepatitis C treated with pegylated interferon and ribavirin

Published:2017-03 Issue:1 Volume:4 Page:4-11
ISSN:2351-9800
Container-title:Advances in Digestive Medicine
language:en
Short-container-title:Advances in Digestive Medicine

Author:

Wen Shi-Chi¹,Cheng Lung-Chih¹,Hsu Jui-Hung¹,Lai Hsin-Wen¹,Shih Pei-Chen²,Tsai Chi-Chang³,Kuo Wu-Hsien³

Affiliation:

1. Division of Gastroenterology; Department of Internal Medicine, Pao-Chien Hospital; Pingtung Taiwan

2. Department of Nursing; Pao-Chien Hospital; Pingtung Taiwan

3. Division of Gastroenterology; Department of Internal Medicine, Kaohsiung Armed Forces General Hospital; Kaohsiung Taiwan

Funder

Pao-Chien hospital, Ping-Tung

Publisher

Wiley

Subject

Gastroenterology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/aid2.12004/fullpdf

Reference30 articles.

1. EASL clinical practice guideline: management of hepatitis C virus infection;J Hepatol,2014

2. Chronic hepatitis C;Rosen;N Engl J Med,2011

3. Diagnosis, management, and treatment of hepatitis C: An update;Ghany;Hepatology,2009

4. Predictors of response to chronic hepatitis C treatment;Ridruejo;Future Virol,2012

5. The natural histology of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients;Sangiovami;Hepatology,2006

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid virologic response in chronic hepatitis C genotype 1: Evaluation of pretreatment factors in patients;Arab Journal of Gastroenterology;2020-12

2. FACTORS AFFECTING EARLY VIRAL LOAD DECLINE AMONG CHRONIC HEPATITIS C PATIENTS RECEIVING PEGYLATED INTERFERON PLUS RIBAVIRIN THERAPY;INDO AM J PHARM SCI;2019

3. Further refining individualized therapy with peginterferon alfa/ribavirin for chronic hepatitis C;Advances in Digestive Medicine;2017-03